Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03616470
Title Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors GlycoMimetics Incorporated
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ITA | IRL | GBR | FRA | ESP | CAN | AUS


No variant requirements are available.